PROGEN
Caroline Odenwald is currently the Head of Marketing at PROGEN. Prior to that, she held positions at the DKFZ German Cancer Research Center, first as a Postdoctoral Research Scientist and later as a PhD Student. Her research projects included the purification and characterization of an HPV L1 based prophylactic vaccine and the characterization of the Human Papillomavirus minor capsid protein L2. Caroline has a Dr. rer. nat. in Molecular Biology from the DKFZ German Cancer Research Center and Heidelberg University, as well as a Master of Science in Molecular Biology Major Cancer Biology from Heidelberg University and a Bachelor of Science in Biology from The Philipp University of Marburg.
This person is not in any teams
PROGEN
Our commitment to scientists is to support them in making new scientific discoveries and groundbreaking research within the life sciences and gene therapy. It is our underlying mission, to help progress new therapies safely, quickly and affordably, so together we can provide solutions to people suffering from poor health and affected by disease every day. PROGEN is made up of a team of experts within AAV and the life sciences and is partnered with gene therapy experts worldwide. We are more than just a manufacturer of antibodies, proteins and ELISAs kits. We strive to understand what scientists need, so we can create solutions and ultimately deliver high quality antibody and exclusive AAV products, which solve your research challenges within academia, biotech and pharma, and ensure PROGEN can continue to be a trusted and reliable partner. Visit our website www.progen.com Imprint: https://bit.ly/3uEZf2h Privacy Statement: https://bit.ly/3dMSgxm